Company / Cost of Revenue
Cooper Companies (The) Cost of Revenue History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$1.4B
FY2025
5-year range
$966.7M / $1.4B
FY2021-FY2025
Trend
+8.5%
vs FY2024
Sector context
#36 of 107
Health Care
What the data says
At $1.4B, Cooper Companies (The)'s cost of revenue ranks #72 of 107 in the Health Care sector. Cost of Revenue has increased for 5 consecutive years, from $896M in FY2020 to $1.4B in FY2025.
Based on SEC 10-K filings.
$1.4B in FY2025 with a 5-year CAGR of +9.5%.
Increased from $1.2B to $1.4B over the past 2 years.
Health Care sector context is included.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- +6.5%
- 5-Year CAGR
- +9.5%
- 10-Year CAGR
- -
Sector benchmark
#72 of 107 in Health CareTop 66% of 107This company $1.4B Sector average $11.8B
▼
-88.0% below sector average
Key checks
Key Insights
- Cooper Companies (The)'s cost of revenue has grown for 5 consecutive years.
- 5-year CAGR of +9.5%, indicating consistent growth.
- In FY2025, cost of revenue increased 8.5% year-over-year.
- Ranks #36 out of 107 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.4B | +8.5% |
| FY2024 | $1.3B | +5.2% |
| FY2023 | $1.2B | +5.7% |
| FY2022 | $1.2B | +20.9% |
| FY2021 | $966.7M | +7.9% |
| FY2020 | $896.1M | -0.1% |
| FY2019 | $896.6M | -0.4% |
| FY2018 | $900.5M | +16.5% |
| FY2017 | $773.2M | -2.6% |
| FY2016 | $793.7M | +9.2% |
As of FY2025 · SEC 10-K · Updated Mar 29, 2026